SUBSCRIBE
SUBSCRIBE
Lone Star Bio

No Antibody Problems with Liraglutide, Baylor College of Medicine Study

April 27, 2010 | 
1 min read

MedPage Today -- BOSTON -- Few patients develop antibodies to liraglutide (Victoza), and the drug’s therapeutic effects aren’t blunted in those who do, researchers said here.

MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Pictured: Man holding tablet computer with scienti
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
 · 
3 min read
 · 
Greg Slabodkin
Pictured: Merck KGaA signage at its headquarters in Darmstadt, Germany
Business
Merck KGaA, Caris Sign Potential $1.4B Deal to Develop First-in-Class ADCs for Cancer
April 4, 2024
 · 
2 min read
 · 
Tyler Patchen
A park in Houston with skyscrapers in the backgrou
Drug Development
Biotech Accelerator Debuts in Houston
October 18, 2023
 · 
3 min read
 · 
Charlotte LoBuono